Crushing the Street: 22 Stocks That Beat Earnings Expectations
Over 100 companies announced earnings results on Monday, August 3, offering a fresh look at how they performed relative to what the market expected of them.
Indivior Pharmaceuticals Inc. (INDV)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Gotham Asset Management Joel Greenblatt | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $35.69 | 1,500 | $53,535.00 | 27,638 | 2026-08-27 | Filing | |
| $36.28 | 1,500 | $54,420.00 | 26,138 | 2026-08-05 | Filing | |
| $31.09 | 8 | $248.68 | 5,724 | 2026-03-13 | Filing | |
| $31.87 | 940 | $29,953.10 | 5,582 | 2026-03-06 | Filing | |
| $32.56 | 31 | $1,009.36 | 5,716 | 2026-03-09 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $41.14 | 18,586 | $764,628.04 | 209,337 | 2026-07-10 | Filing | |
| $38.06 | 18,586 | $707,383.16 | 227,923 | 2026-06-11 | Filing | |
| $37.70 | 36,000 | $1,357,200.00 | 284,751 | 2026-06-08 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% |
News See All
Is Indivior Pharmaceuticals, Inc. (INDV) A Good Stock To Buy Now?
Is INDV a good stock to buy? We came across a bullish thesis on Indivior Pharmaceuticals, Inc. on The Mispricing Desk’s Substack. In this article, we will summarize the bulls’ thesis on INDV.
Indivior Pharmaceuticals Inc (NASDAQ:INDV) Q1 2026 Earnings Call Transcript
Indivior Pharmaceuticals Inc (NASDAQ:INDV) Q1 2026 Earnings Call Transcript April 30, 2026Indivior Pharmaceuticals Inc beats earnings expectations. Reported EPS is $0.96, expectations were $0.64.
Billionaire Howard Marks' 10 Stock Picks with Huge Upside Potential
In this article, we discuss the Billionaire Howard Marks' 10 Stock Picks with Huge Upside Potential.
Indivior Pharmaceuticals Inc (NASDAQ:INDV) Q4 2025 Earnings Call Transcript
Indivior Pharmaceuticals Inc (NASDAQ:INDV) Q4 2025 Earnings Call Transcript February 26, 2026Indivior Pharmaceuticals Inc beats earnings expectations. Reported EPS is $0.82, expectations were $0.65.
Indivior PLC (INDV) Announces Full-Year 2026 Financial Guidance
Indivior PLC (NASDAQ:INDV) is one of the best performing pharma stocks in 2025.
10 Best Performing Pharma Stocks in 2025
In this article, we will look at the 10 Best Performing Pharma Stocks in 2025.
Indivior PLC (NASDAQ:INDV) Q3 2025 Earnings Call Transcript
Indivior PLC (NASDAQ:INDV) Q3 2025 Earnings Call Transcript October 30, 2025Indivior PLC beats earnings expectations. Reported EPS is $0.72, expectations were $0.38.
Indivior (INDV) Jumps to New High on Earnings Blowout, Optimistic Outlook
We recently published 10 Stocks with Outstanding Gains; 9 on Record Highs. Indivior PLC (NASDAQ:INDV) is one of the best-performing stocks on Thursday.
Indivior PLC (INDV) Raises 2025 Guidance After Q2 Revenue Hits $302M
We recently compiled a list of the 12 Best Performing Healthcare Stocks to Buy Right Now. Indivior PLC is one of them.
Hedge Fund Resource Center